Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Metersky

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
ERJ Open Research|July 23, 2024
Brensocatib in non-cystic fibrosis bronchiectasis: ASPEN protocol and baseline characteristicsJames D Chalmers, Pierre-Régis Burgel, Charles L Daley, et al.
Antimicrobial Agents and Chemotherapy|February 10, 2016
Derivation and Multicenter Validation of the Drug Resistance in Pneumonia Clinical Prediction ScoreBrandon J Webb, Kristin Dascomb, Edward Stenehjem, et al.
Chest|February 9, 2012
Will performance measurement lead to better patient outcomes? What are the roles of the National Quality Forum and Medical Specialty Societies?James M O'Brien, Janet Corrigan, Joyce Bruno Reitzner, et al.
JAMA|July 12, 2022
Trends in Adverse Event Rates in Hospitalized Patients, 2010-2019Noel Eldridge, Yun Wang, Mark Metersky, et al.
JAMA|June 4, 2014
Association of azithromycin with mortality and cardiovascular events among older patients hospitalized with pneumoniaEric M Mortensen, Ethan A Halm, Mary Jo Pugh, et al.
Pulmonary Pharmacology & Therapeutics|September 23, 2023
Nontuberculous mycobacterial (NTM) infections in bronchiectasis patients: A retrospective US registry cohort studyMyriam Drysdale, Radmila Choate, Amanda E Brunton, et al.
Chest|November 28, 2016
Adult Patients With Bronchiectasis: A First Look at the US Bronchiectasis Research RegistryTimothy R Aksamit, Anne E O'Donnell, Alan Barker, et al.
Annals of the Rheumatic Diseases|May 9, 2007
Scleroderma lung study (SLS): differences in the presentation and course of patients with limited versus diffuse systemic sclerosisPhilip J Clements, Michael D Roth, Robert Elashoff, et al.
Annals of the American Thoracic Society|March 1, 2023
Immunocompromised Host Pneumonia: Definitions and Diagnostic Criteria: An Official American Thoracic Society Workshop ReportGuang-Shing Cheng, Kristina Crothers, Stefano Aliberti, et al.
Arthritis and Rheumatism|May 1, 2007
Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease: results from the scleroderma lung studyDinesh Khanna, Xiaohong Yan, Donald P Tashkin, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
ERJ Open Research|July 23, 2024
Brensocatib in non-cystic fibrosis bronchiectasis: ASPEN protocol and baseline characteristicsJames D Chalmers, Pierre-Régis Burgel, Charles L Daley, et al.
Antimicrobial Agents and Chemotherapy|February 10, 2016
Derivation and Multicenter Validation of the Drug Resistance in Pneumonia Clinical Prediction ScoreBrandon J Webb, Kristin Dascomb, Edward Stenehjem, et al.
Chest|February 9, 2012
Will performance measurement lead to better patient outcomes? What are the roles of the National Quality Forum and Medical Specialty Societies?James M O'Brien, Janet Corrigan, Joyce Bruno Reitzner, et al.
JAMA|July 12, 2022
Trends in Adverse Event Rates in Hospitalized Patients, 2010-2019Noel Eldridge, Yun Wang, Mark Metersky, et al.
JAMA|June 4, 2014
Association of azithromycin with mortality and cardiovascular events among older patients hospitalized with pneumoniaEric M Mortensen, Ethan A Halm, Mary Jo Pugh, et al.
Pulmonary Pharmacology & Therapeutics|September 23, 2023
Nontuberculous mycobacterial (NTM) infections in bronchiectasis patients: A retrospective US registry cohort studyMyriam Drysdale, Radmila Choate, Amanda E Brunton, et al.
Chest|November 28, 2016
Adult Patients With Bronchiectasis: A First Look at the US Bronchiectasis Research RegistryTimothy R Aksamit, Anne E O'Donnell, Alan Barker, et al.
Annals of the Rheumatic Diseases|May 9, 2007
Scleroderma lung study (SLS): differences in the presentation and course of patients with limited versus diffuse systemic sclerosisPhilip J Clements, Michael D Roth, Robert Elashoff, et al.
Annals of the American Thoracic Society|March 1, 2023
Immunocompromised Host Pneumonia: Definitions and Diagnostic Criteria: An Official American Thoracic Society Workshop ReportGuang-Shing Cheng, Kristina Crothers, Stefano Aliberti, et al.
Arthritis and Rheumatism|May 1, 2007
Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease: results from the scleroderma lung studyDinesh Khanna, Xiaohong Yan, Donald P Tashkin, et al.
Pageof 5